Jobbörse
Finde Jobs in deiner Nähe – ob vor Ort, hybrid oder remote.- Ähnliche Jobs zu: Research Scientist PD
Postdoctoral Researcher
University Health NetworkToronto
Company Description UHN is Canada's #1 hospital and the world's #1 publicly funded hospital. With 10 sites and more than 44,000 Team UHN members, UHN consists of Toronto General Hospital, Toronto Wes
Research Assistant/Technician 3
University of British ColumbiaCanadaStaff - Non UnionJob Category Non Union Technicians and Research AssistantsJob Profile Non Union Salaried - Research Assistant /Technician 3Job Title Research Assistant/Technician 3Department Resea
Scientist - Infectious Diseases - Oxford
ImmunocoreMapledurham
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreMoreton in MarshScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreMortimer CommonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreWaltham Saint LawrenceScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreNorth HinkseyScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreSutton WickScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreStow on the WoldScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreHighclereScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreChalfont Saint GilesScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
